What is the average lead time for orders?

The average lead time is within 15 workdays for both peak and off-season.

Hot Selling Oilless Air Compressor 120L/Min @ 2 Bar with High Quality

Name: Hot Selling Oilless Air Compressor 120L/Min @ 2 Bar with High Quality
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 1928308765

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$60.00-75.00

1 Piece

Sample price:US$75.00/piece.Request sample

Product profile

Customization

Available

Lubrication Style

Oil-free

Cooling System

Air Cooling

Applicable Industry

Hotels, Garment Shops, Building Material Shops

Brand Name

OEM

Voltage

220V/110V(Can Be Customized), 110V 220V 380V

Weight

10.5kg

Air Flow Rate

120L/Min@0bar

Speed

1440/1700rpm

Core Components

Engine, Motor, Pump

Motor

Copper Coil

Transport Package

2 PCS /Carton Case, The Case Size Is: 31*31*25

Specification

271*128*216 mm

Origin

China

Key features

Oil-Free Lubrication: Features an oil-free lubrication style for clean air output and reduced maintenance.

High Air Flow Rate: Delivers a powerful 120L/min air flow rate at 2 bar pressure for efficient operation.

Low Noise Operation: Operates quietly with noise levels kept at or below 55dB(A) for comfortable environments.

Customizable Voltage: Voltage can be customized to 220V, 110V, or 380V to meet specific regional requirements.

Compact & Lightweight: Weighs only 8.5 kg with dimensions of 255*135*212 mm, making it portable and space-saving.

Copper Coil Motor: Equipped with a durable copper coil motor for enhanced efficiency and longevity.

Versatile Applications: Suitable for hotels, garment shops, and building material shops due to its reliable performance.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤2.84hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.